Future Cardia, a medical device company developing an implantable cardiac monitor intended to capture electrocardiogram (ECG) signals, and Artella Solutions Inc. ("ARTELLA"), a remote cardiac ...

Future Cardia implantable cardiac monitoring device, which is awaiting FDA approval, aims to provide long-term ECG data for ...

Future Cardia and Artella Solutions have announced the extension of their strategic partnership focused on cardiac monitoring ...

Earlier this month, Exact reported a record $851 million in third-quarter revenue, which included $666 million from its ...

PAVmed Inc (PAVM) reports significant strides in debt restructuring, strategic partnerships, and technology innovation, ...

Pioneer Valley Cardiology Associates at Mercy Medical Center has introduced the CardioMEMS Heart Failure Monitoring Program, a remote monitoring system that allows for early detection of worsening ...

According into American Heart Association, about 436,000 people in the U.S. die from cardiac arrest. Only about 40% get the immediate help they need.

Bioelectronic hydrogels that could potentially replace existing surgically implanted inflexible devices are currently in ...

Leading brokers expect material outperformance from these two ASX All Ords stocks. The post Top brokers name 2 ASX All Ords ...

Good morning, and welcome to the PAVmed's Third Quarter 2025 Business Update Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I would now like to ...

Drinking caffeinated coffee is safe for people with atrial fibrillation and may help protect against recurrence of the disorder, a new study finds ...